Molecular targeted therapy has become one of the main methods for treating malignant tumors. By using small molecule compounds, monoclonal antibodies, peptides and other substances, it specifically interferes with the signaling pathways that regulate the biological behavior of tumor cells, thus achieving the purpose of inhibiting the growth of malignant tumors with high efficiency and low toxicity. The therapy has greatly promoted the development of modern oncology and will continue to lead the future oncology research and treatment. In order to further promote the construction of oncology discipline in Sichuan province and even in the southwest region, and to build a communication and collaboration platform for clinical staff and scientific researchers of targeted therapy for cancer, the inaugural meeting of the Specialized Committee of Molecular Targeted Therapy for Cancer, sponsored by Sichuan International Medical Exchange & Promotion Association (SCIMEA), was successfully held on August 26, 2022 through a combination of online and offline methods. 

Scene of the meeting

The inaugural meeting was attended by the Secretary General Zhang Mengfan of SCIMEA, Prof. Luo Feng, Prof. Cao Dan, Prof. Zhang Yan and Prof. Jiang Ming from West China Hospital of Sichuan University, Prof. Tang Xiufa from West China Hospital of Stomatology of Sichuan University, Prof. Tan Shisheng from Guizhou Provincial People's Hospital, Prof. Wang Xiaoshan from Sichuan Provincial People's Hospital, Prof. He Miao from Deyang People's Hospital and other experts. In addition, affected by the pandemic, some members of the committee could not attend the inaugural meeting in person, but they witnessed the establishment of the committee together online.

Prof. Cao Dan from West China Hospital of Sichuan University presides over the meeting.

Prof. Luo Feng from West China Hospital of Sichuan University delivers a report on the preparatory work.

First of all, Prof. Luo Feng, one of the initiators of the Specialized Committee of Molecular Targeted Therapy for Cancer of SCIMEA, made a report on the preparatory work. Prof. Luo Feng said that the molecular biological mechanism of tumor development and molecular targeted therapy are the most important topics in today’s oncology research, and molecular targeted therapy has revolutionized modern medical concepts and clinical practice, and will continue to lead the future development of oncology. At present, the research on molecularly targeted therapy for cancer is changing rapidly, with new drugs continuously coming to market and new technologies and protocols continuously being iterated and updated. In order to keep pace with precision medicine and modern oncology, it is necessary to establish a specialized committee focusing on molecular targeted therapy for cancer to provide a platform for doctors and researchers to communicate, learn and promote clinical application.

Mr. Tong Yubo, Director of Academic Conference Affairs Department of SCIMEA, organizes the election.

Later, Tong Yubo, Director of Academic Conference Affairs Department of SCIMEA, organized the election of the Committee and read out the results. And the leaders at all levels of the committee were elected at the scene according to the election provisions in the Articles of Association of Sichuan International Medical Exchange & Promotion Association. As a result, Prof. Luo Feng was elected as chairman with 129 votes, Prof. Cao Dan as chairman designate with 129 votes, 9 experts including Fang Li as deputy chairmen with 129 votes, 37 experts including Bie Jun and Dong Jingsi as members of the standing committee with 129 votes, 96 experts including Cai Lijun and Chen Jing as members, and Liu Yanyang and Wang Li secretaries.

Secretary General Zhang Mengfan reads out the approval for the establishment of the committee.

Secretary General Zhang Mengfan read out the “Approval for the Establishment of the Specialized Committee of Molecular Targeted Therapy for Cancer”, and awarded the approval for the establishment and letter of appointment to the newly-elected chairman Prof. Luo Feng.

Secretary General Zhang Mengfan awards the letter of appointment to the chairman Prof. Luo Feng.

Secretary General Zhang Mengfan awards the letter of appointment to the chairman designate Prof. Cao Dan.

Prof. Luo Feng and Prof. Cao Dan award the letters of appointment to the newly-elected deputy chairmen.

Prof. Luo Feng and Prof. Cao Dan award the letters of appointment to the newly-elected members of the standing committee.

Prof. Luo Feng, chairman of the Specialized Committee of Molecular Targeted Therapy for Cancer of SCIMEA, delivers a speech. 

Prof. Luo Feng, the newly elected chairman of the Specialized Committee of Molecular Targeted Therapy for Cancer, spoke on behalf of all the members of the committee. He expressed his gratitude to all the experts and staff who supported and helped the establishment of the committee, and noted that in the future, under the leadership of SCIMEA, the committee would actively carry out various academic activities and clinical research projects, and make good use of the committee and the platform of the SCIMEA to contribute to the development of overall molecular targeted therapy for cancer in southwest China, so as to benefit all cancer patients and their families. 

Secretary General Zhang Mengfan gives an introduction on SCIMEA.

At the end of the meeting, Secretary General Zhang Mengfan of SCIMEA gave a speech on stage and expressed her warm congratulations on behalf of SCIMEA on the formal establishment of the Specialized Committee of Molecular Targeted Therapy for Cancer. SCIMEA will give full play to the advantages of the industry platform, continuously reach the industry development resources and actively serve the development of the committee. SCIMEA will, based on the needs of the experts, focus on academic exchange, international standards, journal construction, industrial transformation and medical science to provide more professional and precise services for experts and the committee, jointly promote the molecular targeted therapy for cancer and clinical research, and make efforts to contribute to the construction of a healthy Sichuan and a healthy China.

Group photo of some members online 

Group photo

The Specialized Committee of Molecular Targeted Therapy for Cancer of SCIMEA will provide a platform for practitioners related to molecular targeted therapy for cancer to exchange views and learn from each other, promote talent communication and cooperation in this field, so as to improve the overall level of molecular targeted therapy for cancer; through continuing education and training for young physicians, and standardizing the molecular targeted therapies for cancer, the committee will also provide a better development platform for young physicians.

Annex: Member List of the Specialized Committee of Molecular Targeted Therapy for Cancer